Ibrutinib Deacryloylpiperidine CAS 330786-24-8 Ubunyulu > 99.0% (HPLC)
Igama leMchiza | 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
Izithethantonye | Ibrutinib phakathi kwe-N-2;Ibrutinib Deacryloylpiperidine;Ukungcola kwe-Ibrutinib 8;I-5-(4-Phenoxyphenyl) -7H-pyrrolo[2,3-d] pyrimidin-4-ylamine;IBT4A;Ibrutinib N-Despiperidinyl Ukungcola |
Inombolo yeCAS | 330786-24-8 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C17H13N5O |
Ubunzima beMolekyuli | 303.32 |
Indawo yokunyibilika | >262℃(ngoDisemba) |
Ukuxinana | 1.380±0.06 g/cm3 |
IKlasi yeeNgozi | 6.1;Ityhefu |
Iqela lokuPakisha | III |
I-COA kunye ne-MSDS | Iyafumaneka |
Imvelaphi | Shanghai, China |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | I-Off-White ukuya kwi-Khaki Powder |
Ukuchongwa | HNMR, LC-MS |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Ilahleko ekomisweni | <1.00% |
UMax omnye.Ukungcola | <1.00% |
Ukungcola ngokupheleleyo | <1.00% |
Iintsimbi ezinzima (njenge Pb) | <20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi we-Ibrutinib (CAS: 936563-96-1) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.


I-3- (4-Phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-4-amine (CAS: 330786-24-8) i-synthetic intermediate esebenzayo kwi-synthesis ye-Ibrutinib (CAS: 936563-96-1) ).I-Ibrutinib luhlobo lwe-Bruton tyrosine kinase (BTK) inhibitor, ingasetyenziselwa unyango lwe-lymphocytic leukemia engapheliyo (CLL) kunye ne-mantle cell lymphoma (MCL).I-MCL kunye ne-CLL zeze-B-cell non-Hodgkin's lymphoma, ekunzima ukuyinyanga kwaye kulula ukuyiphinda.I-chemical immunotherapy eqhelekileyo ayinakho ukujoliswa, idla ngokuvela kwi-3 okanye i-4 yokusabela okubi.I-Ibrutinib kunye ne-B lymphocytes zinokujolisa nge-BTK eyimfuneko ekubunjweni, ukwahlula, kunye nokusasazwa kolwazi, inqanda umsebenzi we-BTK ngokungaguqukiyo, kwaye inqanda ukwanda kweeseli zesisu kunye nokuphila ngokufanelekileyo.I-Ibrutinib inokuthi ifakwe ngokukhawuleza emva kokulawulwa komlomo, ngexesha le-1 ~ 2h ifikelele ekugxininiseni kwegazi eliphezulu, ukusabela okungalunganga kukunye okanye ezimbini, ngoko ke, i-Ibrutinib iya kuba yinto entsha yonyango lwe-CLL kunye ne-MCL.
-
Ibrutinib Deacryloylpiperidine CAS 330786-24-8 ...
-
(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 I...
-
I-4-Phenoxyphenylboronic Acid CAS 51067-38-0 Ibru...
-
Ibrutinib CAS 936563-96-1 Ubunyulu > 99.5% (HPLC) API
-
Ibrutinib Intermediate CAS 330792-70-6 Ubunyulu >...
-
4-Amino-3-Iodo-1H-Pyrazolo[3,4-d]pyrimidine CAS...
-
I-1-Boc-3-Hydroxypiperidine CAS 85275-45-2 Ibruti...
-
3-Hydroxypiperidine CAS 6859-99-0 Ibrutinib Int...
-
4-Aminopyrazolo[3,4-d]pyrimidine CAS 2380-63-4 ...
-
I-4-Phenoxybenzoic Acid CAS 2215-77-2 Ibrutinib I...